S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

DXR Daxor Corporation

7.765

0.215 (2.85%)

Jan 03 2025 - Closed

Delayed by 15 minutes

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Daxor (NASDAQ:DXR)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Daxor Charts.

Daxor (NASDAQ:DXR)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Daxor Charts.

Daxor Corporation News

Daxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum
Wednesday 18 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 10 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 10 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 10 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)
Thursday 21 November 2024 (1 month ago) • Edgar (US Regulatory)

DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24
Wednesday 9 October 2024 (3 months ago) • GlobeNewswire Inc.

Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Tuesday 8 October 2024 (3 months ago) • GlobeNewswire Inc.

Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
Friday 27 September 2024 (3 months ago) • GlobeNewswire Inc.

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
Thursday 19 September 2024 (4 months ago) • GlobeNewswire Inc.

Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
Thursday 12 September 2024 (4 months ago) • GlobeNewswire Inc.

Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee
Thursday 5 September 2024 (4 months ago) • GlobeNewswire Inc.

Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care
Wednesday 4 September 2024 (4 months ago) • GlobeNewswire Inc.

More Daxor Corporation News Articles

Tonix Pharmaceuticals

Anavex Life Sciences

Global Developments (PK)

Fannie Mae (QB)

TPT Global Tech (CE)

Bioelectronics (PK)

Elite Pharmaceuticals (QB)

Code Green Apparel (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions